Magnesium variability study in haemodialysis patients: intra-patient and inter-patient variability of plasma magnesium before and after hemodialysis.

Magnesium variability study in haemodialysis patients: intra-patient and inter-patient variability of plasma magnesium before and after hemodialysis. - Magnesium variability study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON42883

Enrollment

Registered

2016-07-15

Start date

2016-09-23

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

endstage renal disease kidney disease

Interventions

hemodialysis

magnesium

variability

Eligibility

Age

18 Years to 64 Years

Inclusion criteria

Inclusion criteria: - Age *18 - Hemodialysis with regular three times weekly dialysis schedule - Hemodialysis since at least 3 months - Standard dialysate Mg2+ 0.5 mmol/L - Providing informed consent

Exclusion criteria

Exclusion criteria: - Age

Design outcomes

Primary

Measure	Time frame
Main parameters: Plasma Mg before and after dialysis in 6 consecutive hemodialysis sessions, determined in duplicate. Main endpoints: The intra-individual pre-dialysis variability and post-dialysis (dialysis-induced) variability of plasma Mg and the interindividual variability of pre-dialysis and post-dialysis plasma Mg.	—

Secondary

Measure	Time frame
- The difference in point-estimate of plasma Mg concentration before and after dialysis, using a fixed standard dialysate Mg concentration, as a function of predialysis Mg concentration. - Factors that predict larger differences in point-estimates of plasma Mg before and after dialysis.	—

Countries

The Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)